KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.900
-0.064 (-6.64%)
At close: Dec 5, 2025, 4:00 PM EST
0.888
-0.012 (-1.33%)
After-hours: Dec 5, 2025, 7:59 PM EST
KALA BIO Market Cap
KALA BIO has a market cap or net worth of $7.39 million as of December 5, 2025. Its market cap has decreased by -75.69% in one year.
Market Cap
7.39M
Enterprise Value
16.24M
1-Year Change
-75.69%
Ranking
Category
Stock Price
$0.90
Market Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $7.39M, a decrease of -98.28%. That is a compound annual growth rate of -38.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 7.90M | -75.31% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |